A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Clinical trial NCT07023627 · RECRUITING
Trial details
- NCT number
- NCT07023627
- Sponsor
- Incyte Corporation
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-12
- Primary completion
- 2027-04-27
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.